These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1668212)

  • 21. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
    Przegalinski E; Baran L; Kedrek G
    Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril lacks the antidepressant-like activity in animal models.
    Baran L; Siwanowicz J; Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
    Maj J; Rogóz Z
    J Neural Transm (Vienna); 1999; 106(2):197-211. PubMed ID: 10226939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some central effects of repeated treatment with fluvoxamine.
    Maj J; Dereń A; Moryl E
    Pol J Pharmacol Pharm; 1989; 41(4):305-12. PubMed ID: 2576810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-like effects of selegiline in the forced swim test.
    Shimazu S; Minami A; Kusumoto H; Yoneda F
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):563-71. PubMed ID: 16139174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.
    Heeringa MJ; d'Agostini F; DeBoer P; DaPrada M; Damsma G
    J Neural Transm (Vienna); 1997; 104(6-7):593-603. PubMed ID: 9444560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation.
    Maj J; Rogóz Z; Skuza G; Margas W
    J Neural Transm (Vienna); 1998; 105(2-3):329-42. PubMed ID: 9660111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Superata J
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):101-12. PubMed ID: 1977408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of preparations that alter catecholaminergic processes on the serotoninergic syndrome of head twitching in mice].
    Shchelkunov EL
    Farmakol Toksikol; 1979; 42(5):470-4. PubMed ID: 39775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some central pharmacological effects of (+)- and (-)-oxaprotiline.
    Maj J; Rogóź Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1990; 80(2):129-43. PubMed ID: 2317315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney.
    Fernandes MH; Soares-da-Silva P
    J Neural Transm Suppl; 1990; 32():155-9. PubMed ID: 2089083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.